v3.26.3
Other Operating Income (Expense), net (Tables)
9 Months Ended
Sep. 30, 2026
Unusual or Infrequent Items, or Both [Abstract]  
Schedule of Other Operating Income (Expense), Net
Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
(In millions)
Restructuring(1)
Employee-related charges$(4.5)$(0.9)$(25.4)$(9.2)
Asset abandonment and other restructuring costs(5.0)(0.4)(22.5)(20.1)
Intangible and tangible asset impairments, excluding goodwill(2)
— (273.9)— (273.9)
Gains (losses) on disposals and other(3)
0.2 — (10.1)2.9 
Other operating income (expense), net$(9.3)$(275.2)$(58.0)$(300.3)
(1)On October 20, 2025, we announced the Americas Restructuring Plan designed to create a leaner, more agile Americas segment while advancing our ability to reinvest in the business and position us for future growth. The plan resulted in $5.1 million of employee-related charges recorded during the nine months ended September 30, 2026. The cumulative restructuring charges recorded through September 30, 2026 related to the Americas Restructuring Plan were $33.8 million. These actions are substantially complete and any remaining future charges are expected to be immaterial.
During the first quarter of 2026, we committed to various cost savings actions designed to optimize our supply chain within the Americas segment, which resulted in restructuring charges including accelerated depreciation in excess of normal depreciation charges of $1.9 million and $12.0 million during the three and nine months ended September 30, 2026, respectively. We anticipate additional charges related to these committed actions to be approximately $5 million to $10 million, with the majority of these charges to be recorded during the remainder of 2026 as well as in 2027.
Also, during the first quarter and third quarter of 2026, we committed to various restructuring actions in the EMEA&APAC segment, including the closure of several small breweries, alongside other operational changes designed to unlock efficiencies as well as modernize and simplify the EMEA&APAC segment to fund growth. During the three and nine months ended September 30, 2026, we recorded employee-related charges of $4.4 million and $19.7 million, respectively, as well as accelerated depreciation in excess of normal depreciation charges of $5.2 million and $10.2 million, respectively, related to these actions. We anticipate additional charges related to these committed actions to be approximately $15 million to $20 million, with the majority of these charges to be recorded during the remainder of 2026 as well as in 2027.
During the third quarter of 2024, we made the decision to wind down or sell certain of our U.S. craft businesses and related facilities and recorded employee-related and asset abandonment charges. During the first quarter of 2025, we incurred accelerated depreciation in excess of normal depreciation of $17.9 million related to this action. Restructuring charges related to these actions are complete.
(2)During the third quarter of 2025, we recognized a partial impairment charge of $198.6 million related to the Staropramen family of brands indefinite-lived intangible asset in our EMEA&APAC segment. Also during the third quarter of 2025, we recognized a full impairment charge of $75.3 million related to the Blue Run Spirits definite-lived intangible asset in our Americas segment.
(3)During the second quarter of 2026, we made the decision to exit a brand in our Americas segment and, as a result, recorded $8.1 million of accelerated amortization of the brand intangible.
Schedule of Accrued Restructuring Balance
The below table presents a rollforward of the Americas Restructuring Plan accrued restructuring balance related to employee-related charges. The accrued restructuring balances for the other remaining restructuring projects are immaterial.
(In millions)
As of December 31, 2025
$28.3 
Charges incurred and changes in estimates5.1 
Payments made(26.1)
As of September 30, 2026
$7.3